Cleveland, Ohio 44195

  • Optic Neuritis

Purpose:

To evaluate the ability of different spectral domain optical coherence tomography (OCT) devices, as well as different acquisition and analysis packages, to detect disease progression in patients with multiple sclerosis with and without a history of optic neuritis


Study summary:

Optical coherence tomography imaging of the retina has been shown to be an effective non invasive method to study retinal changes associated with multiple sclerosis induced optic neuritis. The retina is a unique structure in that it is an unmyelinated part of the central nervous system (CNS). However, it is uncertain which layer of the retina provides the best correlation with MS disease. The investigators propose a prospective, case-control study to compare OCT measurements from different parts of the retina of MS patients with optic neuritis, those without optic neuritis, and healthy controls. The investigators will then correlate the OCT measurements to clinical measures of disease. This will allow future studies to use OCT technology as a primary outcome in studying MS axonal and cell body injury of the CNS, as well as evaluating strategies in treating MS.


Criteria:

Inclusion criteria (MS with acute optic neuritis group): - History of unilateral optic neuritis as a manifestation of multiple sclerosis. - Age between 18 and 65, inclusive. - Ability to perform adequate OCT exam. - Able to provide informed consent to participate in study. Exclusion criteria (MS with acute optic neuritis group): - Refractive error greater than ±6 diopters. Inclusion criteria (MS without acute optic neuritis group): - History of multiple sclerosis without optic neuritis - Age between 18 and 65, inclusive. - Ability to perform adequate OCT exam. - Able to provide informed consent to participate in study. Exclusion criteria (MS without acute optic neuritis group): - Refractive error greater than ±6 diopters. Inclusion criteria (healthy controls): - Age between 18 and 65, inclusive. - Ability to perform adequate OCT exam. - Able to provide informed consent to participate in the study. Exclusion criteria (healthy controls): - Prior history of neurological disease. - First degree relative with MS. - Refractive error greater than ±6 diopters.


NCT ID:

NCT01774123


Primary Contact:

Principal Investigator
Peter K. Kaiser, MD
Cleveland Clinic Cole Eye Institute


Backup Contact:

N/A


Location Contact:

Cleveland, Ohio 44195
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 13, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.